Ignite Creation Date:
2024-05-06 @ 1:14 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01764477
Status:
COMPLETED
Last Update Posted:
2017-08-17
First Post:
2012-12-12
Brief Title:
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
Sponsor:
Prism Pharma Co Ltd
Organization:
Prism Pharma Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pancreatic Adenocarcinoma |
| Advanced Pancreatic Cancer |
| Metastatic Pancreatic Cancer |
Keywords: